Non-Alcoholic Fatty Liver Disease Trial, Recruiting (NCT06720766)

Non-Alcoholic Fatty Liver Disease Trial, Recruiting NCT06720766 Sponsor: The Third People's Hospital of Chengdu Condition: Non-Alcoholic Fatty Liver Disease

Printed from Voxsanity (voxsanity.com.au) — NCT06720766 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Non Alcoholic Fatty Liver Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years old or older and have agreed in writing to take part in the study
You are already planning to have weight-loss (bariatric) surgery and a liver biopsy to check for a suspected liver condition called MASLD (a type of fatty liver disease)
You are already scheduled to have a liver scan called a FibroScan

Who may not be able to join:

You have a build-up of fluid in your abdomen (belly), or you are pregnant
You have an active implanted medical device in your body, such as a pacemaker or defibrillator
You have previously had a liver transplant
You have heart failure and/or a significant problem with one or more of your heart valves
You have a condition called haemochromatosis (a disorder where too much iron builds up in the body)
You do not wish to have a liver biopsy or blood tests as part of the study
You have been diagnosed with an active cancer or another terminal (life-limiting) illness
You have taken part in another clinical trial within the last 30 days

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +8615803838681

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06720766

Sponsor: The Third People's Hospital of Chengdu

Phase: Not Applicable

Status: Recruiting

Condition: Non-Alcoholic Fatty Liver Disease

Trial contact: +8615803838681

More information: https://clinicaltrials.gov/study/NCT06720766

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years old or older and have agreed in writing to take part in the study
You are already planning to have weight-loss (bariatric) surgery and a liver biopsy to check for a suspected liver condition called MASLD (a type of fatty liver disease)
You are already scheduled to have a liver scan called a FibroScan

Who may not be able to join:

You have a build-up of fluid in your abdomen (belly), or you are pregnant
You have an active implanted medical device in your body, such as a pacemaker or defibrillator
You have previously had a liver transplant
You have heart failure and/or a significant problem with one or more of your heart valves
You have a condition called haemochromatosis (a disorder where too much iron builds up in the body)
You do not wish to have a liver biopsy or blood tests as part of the study
You have been diagnosed with an active cancer or another terminal (life-limiting) illness
You have taken part in another clinical trial within the last 30 days

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

The Third People's Hospital of Chengdu

Registry

ClinicalTrials.gov

Start date

24 October 2023

Est. completion

31 March 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Diagnostic accuracy; Cut-off values

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov